Quantum Extremal Learning
Authors:
Savvas Varsamopoulos,
Evan Philip,
Herman W. T. van Vlijmen,
Sairam Menon,
Ann Vos,
Natalia Dyubankova,
Bert Torfs,
Anthony Rowe,
Vincent E. Elfving
Abstract:
We propose a quantum algorithm for `extremal learning', which is the process of finding the input to a hidden function that extremizes the function output, without having direct access to the hidden function, given only partial input-output (training) data. The algorithm, called quantum extremal learning (QEL), consists of a parametric quantum circuit that is variationally trained to model data in…
▽ More
We propose a quantum algorithm for `extremal learning', which is the process of finding the input to a hidden function that extremizes the function output, without having direct access to the hidden function, given only partial input-output (training) data. The algorithm, called quantum extremal learning (QEL), consists of a parametric quantum circuit that is variationally trained to model data input-output relationships and where a trainable quantum feature map, that encodes the input data, is analytically differentiated in order to find the coordinate that extremizes the model. This enables the combination of established quantum machine learning modelling with established quantum optimization, on a single circuit/quantum computer. We have tested our algorithm on a range of classical datasets based on either discrete or continuous input variables, both of which are compatible with the algorithm. In case of discrete variables, we test our algorithm on synthetic problems formulated based on Max-Cut problem generators and also considering higher order correlations in the input-output relationships. In case of the continuous variables, we test our algorithm on synthetic datasets in 1D and simple ordinary differential functions. We find that the algorithm is able to successfully find the extremal value of such problems, even when the training dataset is sparse or a small fraction of the input configuration space. We additionally show how the algorithm can be used for much more general cases of higher dimensionality, complex differential equations, and with full flexibility in the choice of both modeling and optimization ansatz. We envision that due to its general framework and simple construction, the QEL algorithm will be able to solve a wide variety of applications in different fields, opening up areas of further research.
△ Less
Submitted 5 May, 2022;
originally announced May 2022.
Blood-based metabolic signatures in Alzheimer's disease
Authors:
Francisca A. de Leeuw,
Carel F. W. Peeters,
Maartje I. Kester,
Amy C. Harms,
Eduard A. Struys,
Thomas Hankemeier,
Herman W. T. van Vlijmen,
Sven J. van der Lee,
Cornelia M. van Duijn,
Philip Scheltens,
Ayşe Demirkan,
Mark A. van de Wiel,
Wiesje M. van der Flier,
Charlotte E. Teunissen
Abstract:
Introduction: Identification of blood-based metabolic changes might provide early and easy-to-obtain biomarkers.
Methods: We included 127 AD patients and 121 controls with CSF-biomarker-confirmed diagnosis (cut-off tau/A$β_{42}$: 0.52). Mass spectrometry platforms determined the concentrations of 53 amine, 22 organic acid, 120 lipid, and 40 oxidative stress compounds. Multiple signatures were as…
▽ More
Introduction: Identification of blood-based metabolic changes might provide early and easy-to-obtain biomarkers.
Methods: We included 127 AD patients and 121 controls with CSF-biomarker-confirmed diagnosis (cut-off tau/A$β_{42}$: 0.52). Mass spectrometry platforms determined the concentrations of 53 amine, 22 organic acid, 120 lipid, and 40 oxidative stress compounds. Multiple signatures were assessed: differential expression (nested linear models), classification (logistic regression), and regulatory (network extraction).
Results: Twenty-six metabolites were differentially expressed. Metabolites improved the classification performance of clinical variables from 74% to 79%. Network models identified 5 hubs of metabolic dysregulation: Tyrosine, glycylglycine, glutamine, lysophosphatic acid C18:2 and platelet activating factor C16:0. The metabolite network for APOE $ε$4 negative AD patients was less cohesive compared to the network for APOE $ε$4 positive AD patients.
Discussion: Multiple signatures point to various promising peripheral markers for further validation. The network differences in AD patients according to APOE genotype may reflect different pathways to AD.
△ Less
Submitted 21 September, 2017;
originally announced September 2017.
